The role of adenosine receptor ligands on inflammatory pain: possible modulation of TRPV1 receptor function

被引:12
|
作者
Haddad, Mansour [1 ]
Alsalem, Mohammad [2 ]
Aldossary, Sara A. A. [4 ]
Kalbouneh, Heba [2 ]
Jaffal, Sahar M. M. [5 ]
Alshawabkeh, Qusai [2 ]
Al Hayek, Sa'ed [2 ]
Abdelhai, Omar [6 ]
Barakat, Noor A. A. [2 ]
El-Salem, Khalid [3 ]
机构
[1] Yarmouk Univ, Fac Pharm, Irbid 21163, Jordan
[2] Univ Jordan, Sch Med, Amman 11942, Jordan
[3] Jordan Univ Sci & Technol, Fac Med, Irbid 22110, Jordan
[4] King Faisal Univ, Fac Clin Pharm, Al Hasa, Saudi Arabia
[5] Univ Jordan, Fac Sci, Biol Sci, Amman 11942, Jordan
[6] Al Khalidi Hosp & Med Ctr, Ibn Khaldon St 39, Amman, Jordan
关键词
Pain; Adenosine receptors; Inflammation; TRPV1; SPINAL-CORD; NEUROPATHIC PAIN; MICE LACKING; CAPSAICIN RECEPTOR; ACTIVATION; AGONISTS; FORMALIN; A(1); ANTINOCICEPTION; INHIBITION;
D O I
10.1007/s10787-022-01127-3
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Chronic pain has a debilitating consequences on health and lifestyle. The currently available analgesics are often ineffective and accompanied by undesirable adverse effects. Although adenosine receptors (AR) activation can affect nociceptive, inflammatory, and neuropathic pain states, the specific regulatory functions of its subtypes (A(1), A(2A), A(2B) and A(3) ARs) are not fully understood. The aim of this study was to investigate the role of different AR ligands on inflammatory pain. The von Frey filament test was used to assess the anti-nociceptive effects of adenosine ligands on Complete Freund's Adjuvant (CFA)-induced mechanical allodynia in (180-220 g) adult male Sprague Dawley rats (expressed as paw withdrawal threshold, PWT). Neither the A(2A)AR selective agonist CGS 21680 hydrochloride (0.1, 0.32 and 1 mg/kg) nor the A(2B)AR selective agonist BAY 60-6583 (0.1, 0.32 and 1 mg/kg) produced any significant reversal of the PWT. However, the A(1)AR selective agonist ( +/-)-5'-Chloro-5'-deoxy-ENBA, the A(3)AR selective agonist 2-Cl-IB-MECA, the A(2A)AR selective antagonist ZM 241385 and the A(2B)AR selective antagonist PSB 603 produced a significant reversal of the PWT at the highest dose of 1 mg/kg. Co-administration of the selective antagonists of A(1)AR and A(3)AR PSB36 (1 mg/ml) and MRS-3777 (1 mg/ml); respectively, significantly reversed the anti-nociceptive effects of their corresponding agonists. Furthermore, calcium imaging studies reveled that the effective AR ligands in the behavioral assay also significantly inhibit capsaicin-evoked calcium responses in cultured rat dorsal root ganglia (DRG) neurons. In conclusion, modulating the activity of the transient receptor potential vanilloid 1 (TRPV1) receptor by ARs ligands could explain their anti-nociceptive effects observed in vivo. Therefore, the cross talk between ARs and TRPV1 receptor may represent a promising targets for the treatment of inflammatory pain conditions.
引用
收藏
页码:337 / 347
页数:11
相关论文
共 50 条
  • [31] ANANDAMIDE AND THE VANILLOID RECEPTOR (TRPV1)
    Toth, Attila
    Blumberg, Peter M.
    Boczan, Judit
    VITAMINS AND HORMONES: ANANDAMIDE AN ENDOGENOUS CANNABINOID, 2009, 81 : 389 - 419
  • [32] Interaction with Phosphoinositides Confers Adaptation onto the TRPV1 Pain Receptor
    Yao, Jing
    Qin, Feng
    PLOS BIOLOGY, 2009, 7 (02): : 350 - 363
  • [33] Role of rat sensory neuron-specific receptor (rSNSR1) in inflammatory pain: Contribution of TRPV1 to SNSR signaling in the pain pathway
    Ndong, Christian
    Pradhan, Amynah
    Puma, Carole
    Morello, Jean-Pierre
    Hoffert, Cyrla
    Groblewski, Thierry
    O'Donnell, Dajan
    Laird, Jennifer M. A.
    PAIN, 2009, 143 (1-2) : 130 - 137
  • [34] The role of endogenous molecules in modulating pain through transient receptor potential vanilloid 1 (TRPV1)
    Morales-Lazaro, Sara L.
    Simon, Sidney A.
    Rosenbaum, Tamara
    JOURNAL OF PHYSIOLOGY-LONDON, 2013, 591 (13): : 3109 - 3121
  • [35] TRPV1 (vanilloid receptor, capsaicin receptor) agonists and antagonists
    Appendino, G
    Muñoz, E
    Fiebich, BL
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2003, 13 (12) : 1825 - 1837
  • [36] The effects of the TRPV1 antagonist SB-705498 on TRPV1 receptor-mediated activity and inflammatory hyperalgesia in humans
    Chizh, Boris A.
    O'Donnell, Mary B.
    Napolitano, Antonella
    Wang, Jie
    Brooke, Allison C.
    Aylott, Mike C.
    Bullman, Jonathan N.
    Gray, Emily J.
    Lai, Robert Y.
    Williams, Pauline M.
    Appleb, Jonathan M.
    PAIN, 2007, 132 (1-2) : 132 - 141
  • [37] Vanilloid Receptor-1 (TRPV1) Expression and Function in the Vasculature of the Rat
    Toth, Attila
    Czikora, Agnes
    Pasztor, Eniko T.
    Dienes, Beatrix
    Bai, Peter
    Csernoch, Laszlo
    Rutkai, Ibolya
    Csato, Viktoria
    Manyine, Ivetta S.
    Porszasz, Robert
    Edes, Istvan
    Papp, Zoltan
    Boczan, Judit
    JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 2014, 62 (02) : 129 - 144
  • [38] Laser Modulation of Heat and Capsaicin Receptor TRPV1 Leads to Thermal Antinociception
    Ryu, J. -J.
    Yoo, S.
    Kim, K. Y.
    Park, J. -S.
    Bang, S.
    Lee, S. H.
    Yang, T. -J.
    Cho, H.
    Hwang, S. W.
    JOURNAL OF DENTAL RESEARCH, 2010, 89 (12) : 1455 - 1460
  • [39] Neuronal lipid rafts regulate neuropathic pain via modulation of TRPV1 and NMDA receptor membrane dynamics
    Pelaez, Juliana Navia
    Capettini, Luciano
    Yaksh, Tony
    Miller, Yury
    BIOPHYSICAL JOURNAL, 2022, 121 (03) : 313A - 313A
  • [40] TRPV1 channel modulation by hyaluronan reduces pain
    de la Pena, Elvira
    Gomis, Ana
    Ferrer-Montiel, Antonio
    Belmonte, Carlos
    CHANNELS, 2016, 10 (02) : 81 - 82